Skip to main content
Premium Trial:

Request an Annual Quote

The Near Future?

Personalized medicine is nearly here, writes Greg Lucier, the chairman and chief executive officer of Life Technologies, in the Vancouver Sun. "Sooner rather than later, genomic sequencing will become the norm for patient care," he says. Lucier then envisions what a future visit to the doctor's office will entail: the patient is sequenced, the doctor can look up that data and the mutations it contains and prescribe a certain therapy, then the patient is re-sequenced and the doctor can adjust the treatment to account for new mutation information. "We see a future where DNA sequencing will be as commonplace as a stethoscope is today. Personalized medicine will provide hope where there was none and at the end of the day, will make life even better," he says.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.